Journal of Molecular Medicine-Jmm

Papers
(The H4-Index of Journal of Molecular Medicine-Jmm is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches83
Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases58
ER stress activates immunosuppressive network: implications for aging and Alzheimer’s disease56
The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells55
Rewiring of glucose metabolism defines trained immunity induced by oxidized low-density lipoprotein53
Cancer research using organoid technology50
Glycosylation is a key in SARS-CoV-2 infection50
The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis45
Disturbed lipid and amino acid metabolisms in COVID-19 patients44
Expanding and validating the biomarkers for mitochondrial diseases43
AMPK: a key regulator of energy stress and calcium-induced autophagy43
SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α43
Organoids of the female reproductive tract42
COVID-19: molecular diagnostics overview41
Evolving AAV-delivered therapeutics towards ultimate cures41
A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia41
Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions39
Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies39
Obesity and its impact on COVID-1938
Mitochondrial respiratory supercomplexes in mammalian cells: structural versus functional role37
Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis35
Lysosomal storage diseases: current therapies and future alternatives34
High glucose: an emerging association between diabetes mellitus and cancer progression33
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis33
Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell33
Diagnosing the novel SARS-CoV-2 by quantitative RT-PCR: variations and opportunities33
Novel therapeutic approaches for treatment of COVID-1933
Genetic engineering in organoids33
Extracellular vesicles-associated tRNA-derived fragments (tRFs): biogenesis, biological functions, and their role as potential biomarkers in human diseases33
ACE polymorphisms and COVID-19-related mortality in Europe32
Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis32
Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregul31
TCF21: a critical transcription factor in health and cancer31
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis31
The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection31
0.051196813583374